CRWV insider sales: 150,000-share Form 144 filing; multiple 10b5-1 trades in Aug–Sep 2025

Rhea-AI Filing Summary

Form 144 for CoreWeave, Inc. (CRWV) discloses a proposed sale of 150,000 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately for 09/30/2025 with an aggregate market value of $18,378,000.00. The filer reports these shares were acquired as Founders Shares on 11/13/2017. The filing shows numerous recent executions of 10b5-1 sales by related parties on dates in August and September 2025, each selling blocks of 250,000 and 375,000 shares with multi-million dollar gross proceeds. The filing includes the filer’s representation regarding absence of undisclosed material adverse information and references Rule 10b5-1 trading plans where indicated.

Positive

• Planned 10b5-1 executions are documented, showing trades were implemented under established trading plans
• Acquisition history is clear: the 150,000 shares were acquired as founders shares on 11/13/2017

Negative

• Significant insider share dispositions are recorded in August and September 2025, with multiple blocks of 250,000 and 375,000 shares sold for multi-million dollar proceeds
• Proposed sale of 150,000 shares valued at $18,378,000 could represent meaningful insider selling pressure (factual sale amount and value shown)

Insights

Financial Analyst

TL;DR: Insider-related sales continue with a proposed 150,000-share sale valued at $18.38M and multiple 10b5-1 executions in Aug–Sep 2025.

The filing documents a scheduled sale of 150,000 common shares via Morgan Stanley on 09/30/2025, acquired as founders shares in 2017. The record of multiple recent 10b5-1 sales shows significant share dispositions by named sellers in August and September 2025, each generating tens of millions in gross proceeds. From a market-impact perspective, these are material share volumes relative to single-day trading blocks but the filing itself provides no information on use of proceeds, rationale, or effect on outstanding share count beyond the stated figures.

Corporate Governance Expert

TL;DR: The filing is a routine Rule 144 notice documenting an intended sale and multiple 10b5-1 plan executions; governance disclosures are present but minimal.

The notice includes the required representation that the seller is not aware of undisclosed material adverse information and cites a 10b5-1 framework in past sales, indicating planned trading activity. The document supplies acquisition details (founders shares dated 11/13/2017) and broker information. There are no governance events, departures, or regulatory actions disclosed in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	150000	18378000.00	370470348	09/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			150000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/23/2025	250000	32957025.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/23/2025	375000	49435537.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	250000	29542575.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	375000	44313862.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	250000	24866825.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	375000	37301250.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CoreWeave (CRWV) report?

The filing reports a proposed sale of 150,000 common shares09/30/2025 valued at $18,378,000.00.

When were the shares proposed for sale originally acquired?

The shares were acquired as Founders Shares on 11/13/2017 and the filing lists the acquisition date as 11/13/2017.

Are there recent insider sales related to this filing?

Yes. The filing lists multiple 10b5-1 sales in August and September 2025, including repeated blocks of 250,000 and 375,000 shares with substantial gross proceeds on each date.

Which broker is handling the proposed sale?

The sale is to be handled by Morgan Stanley Smith Barney LLC, Executive Financial Services located at 1 New York Plaza, New York, NY.

Does the filing state any undisclosed material adverse information?

The filer represents by signature that they do not know any material adverse information

How many shares outstanding does the filing report?

The filing reports 370,470,348 shares outstanding for the issuer in the securities information table.